[
    [
        {
            "time": "",
            "original_text": "[强烈推荐-A评级] 昭衍新药(603127)点评：携手凯莱英 开展产业链深度合作",
            "features": {
                "keywords": [
                    "昭衍新药",
                    "凯莱英",
                    "产业链",
                    "深度合作"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物技术"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[强烈推荐-A评级] 昭衍新药(603127)点评：携手凯莱英 开展产业链深度合作",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[买入评级] 凯莱英(002821)重大事项点评：联手国内外龙头 共同打造一站式服务体系",
            "features": {
                "keywords": [
                    "凯莱英",
                    "国内外龙头",
                    "一站式服务"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[买入评级] 凯莱英(002821)重大事项点评：联手国内外龙头 共同打造一站式服务体系",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "昭衍新药与凯莱英签署战略合作 形成良性业务循环",
            "features": {
                "keywords": [
                    "昭衍新药",
                    "凯莱英",
                    "战略合作",
                    "良性循环"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "研发生产"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "昭衍新药与凯莱英签署战略合作 形成良性业务循环",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "[强烈推荐评级] 凯莱英(002821)事项点评：战略合作CRO 持续强化新药研发生产一站式服务",
            "features": {
                "keywords": [
                    "凯莱英",
                    "战略合作",
                    "CRO",
                    "新药研发",
                    "一站式服务"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "研发外包"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[强烈推荐评级] 凯莱英(002821)事项点评：战略合作CRO 持续强化新药研发生产一站式服务",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]